by CheckRare Staff | Sep 19, 2023
Shoshana Shendelman, PhD, President and Chief Executive Officer of Applied Therapeutics, explains the urgency of finding newer treatment options for galactosemia patients. Galactosemia is a rare, metabolic disorder that affects an individual’s...
by CheckRare Staff | Sep 18, 2023
Mary McGowan, MD, chief medical officer of the Family Heart Foundation explains when it is recommended that children be screened with a lipid profile. T The American Academy of Pediatrics and the National Heart, Lung, and Blood Institute of the NIH...
by CheckRare Staff | Sep 14, 2023
Ben Munoz, co-founder of Ben’s Friends, talks about his non-profit organization. Ben’s Friends is a 501(c)(3) non-profit designed to provide a network for patients with rare diseases or chronic illnesses. Its goal is to be a safe and supportive place for...
by CheckRare Staff | Sep 12, 2023
Acromegaly, a serious and rare disease caused by a pituitary adenoma, affects thousands of individuals worldwide. The excess secretion of growth hormone (GH) leads to the production of insulin-like growth factor 1 (IGF-1), resulting in systemic complications and...
by CheckRare Staff | Sep 6, 2023
Shoshana Shendelman, PhD, President and Chief Executive Officer of Applied Therapeutics, discusses the results of the Phase 3 clinical trial testing govorestat to treat galactosemia. Galactosemia is a rare, metabolic disorder that affects a person’s...
